VitaNova Life Sciences Corp (VNOV) stock
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
$4.50+0.50 (+12.50%)
Close on Oct 19, 2026Market cap $37.52MP/E –Yield –
VitaNova Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
VitaNova Life Sciences's operating cash flow for the twelve months ending Jul 31, 2026 was $557.56K, down 42.0% year over year. For fiscal 2026 it was $814.41K, up 322.5% from the year before. The highest annual figure on record is $814.41K in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $814.41K | +322.5% |
| FY2025 | Apr 30, 2025 | $192.77K | – |
| FY2024 | Apr 30, 2024 | -$375.88K | – |
| FY2023 | Apr 30, 2023 | -$18.38K | -552.5% |
| FY2022 | Apr 30, 2022 | $4.06K | – |
| FY2021 | Apr 30, 2021 | -$42.29K | – |
| FY2020 | Apr 30, 2020 | -$53.58K | – |
| FY2019 | Apr 30, 2019 | -$49.11K | – |
| FY2017 | Jan 25, 2017 | -$6.49K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $6.97K | -97.4% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | $428.31K | -10.6% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | -$90.38K | -143.3% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | $212.66K | +2327.6% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | $263.81K | – |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | $479.14K | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | $208.88K | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | $8.76K | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -$504.00K | – |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | -$191.19K | – |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | -$150.56K | – |
| Q2 FY2024CQ3 2023 | Oct 31, 2023 | -$7.99K | -250.6% |
| Q1 FY2024CQ2 2023 | Jul 31, 2023 | -$26.15K | -485.6% |
| Q4 FY2023CQ1 2023 | Apr 30, 2023 | -$2.29K | – |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | -$28.18K | -637.5% |
| Q2 FY2023CQ3 2022 | Oct 31, 2022 | $5.31K | -72.9% |
| Q1 FY2023CQ2 2022 | Jul 31, 2022 | $6.78K | – |
| Q4 FY2022CQ1 2022 | Apr 30, 2022 | -$13.83K | – |
| Q3 FY2022CQ4 2021 | Jan 31, 2022 | $5.24K | – |
| Q2 FY2022CQ3 2021 | Oct 31, 2021 | $19.59K | – |
| Q1 FY2022CQ2 2021 | Jul 31, 2021 | -$6.94K | – |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $0 | – |
| Q3 FY2021CQ4 2020 | Jan 31, 2021 | -$11.72K | – |
| Q2 FY2021CQ3 2020 | Oct 31, 2020 | -$30.57K | – |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $0 | – |
| Q4 FY2020CQ1 2020 | Apr 30, 2020 | -$14.80K | – |
| Q3 FY2020CQ4 2019 | Jan 31, 2020 | -$7.22K | – |
| Q2 FY2020CQ3 2019 | Oct 31, 2019 | -$11.68K | – |
| Q1 FY2020CQ2 2019 | Jul 31, 2019 | -$19.88K | – |
| Q4 FY2019CQ1 2019 | Apr 30, 2019 | -$13.65K | – |
| Q1 FY2019CQ2 2018 | Jul 31, 2018 | -$10.82K | – |
See a number that looks wrong?